Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status
Crossref DOI link: https://doi.org/10.1007/s40263-016-0393-9
Published Online: 2016-11-08
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Swart, Tara
Hurley, Michael J.
License valid from 2016-11-08
